Latest news
Loading news…
Sorriso Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Diego, California, United States Founded 2020 11-50 employees For Profit
Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Patents
15
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 27
- Patents granted
- 15
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $101K
Company Info
- Founded
- 2020
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 20
- HQ
- San Diego, California, United States
- Region
- Greater San Diego Area, West Coast, Western US
- Diversity spotlight
- Women Founded; Women Led
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 1.2
- Trend (30d)
- 0.8
- Trend (90d)
- -0.4
2
professional contacts at Sorriso Pharmaceuticals
Contact execs at Sorriso Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Sorriso Pharmaceuticals
Loading news…
FAQs about Sorriso Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.